WTO-compliant remission of tax scheme
The Cabinet Committee on Economic Affairs on 13 March 2020 approved a World Trade Organisation (WTO)-compliant scheme for reimbursement of taxes and duties to exporters.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23106-wto-compliant-remission-of-tax-scheme.html
#WTO #taxscheme #GST #RoDTEP #MEIS
Guidelines for Ind AS
The Reserve Bank on 13 March 2020 came out with regulatory guidelines for implementation of Indian Accounting Standards (Ind AS) by non-banking financial companies (NBFCs) and asset reconstruction companies (ARCs) while preparing their financial results.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23105-guidelines-for-ind-as.html
#Guidelines #IndAS #NBFCs #ARCs #ACB
Centre declares coronavirus as 'notified disaster'
In the wake of spurt in cases of coronavirus pandemic in the country, the Ministry of Home Affairs on 14 March 2020 decided to treat Covid-19 as a "notified disaster".
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23104-centre-declares-coronavirus-as-notified-disaster.html
#coronavirus #notifieddisaster #SDRF #WHO
Community transmission of Covid-19
To rule out community transmission of Covid-19, over a thousand samples of influenza- or pneumonia-like illnesses, taken from patients without any travel history or contact with infected persons, would now also be tested for coronavirus every week.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23103-community-transmission-of-covid-19.html
#Communitytransmission #Covid19 #DHR-ICMR #coronavirus
Syrian children in need due to war: UN
The UN children’s organization UNICEF issued a plea on 13 March 2020 to support Syrian children as the war in Syria nears the start of its 10th year. A child dies every 10 hours as a result of the war, the organization said.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23102-syrian-children-in-need-due-to-war-un.html
#UN #war #UNICEF #Syrianchildren #BasharAssad
The Cabinet Committee on Economic Affairs on 13 March 2020 approved a World Trade Organisation (WTO)-compliant scheme for reimbursement of taxes and duties to exporters.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23106-wto-compliant-remission-of-tax-scheme.html
#WTO #taxscheme #GST #RoDTEP #MEIS
Guidelines for Ind AS
The Reserve Bank on 13 March 2020 came out with regulatory guidelines for implementation of Indian Accounting Standards (Ind AS) by non-banking financial companies (NBFCs) and asset reconstruction companies (ARCs) while preparing their financial results.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23105-guidelines-for-ind-as.html
#Guidelines #IndAS #NBFCs #ARCs #ACB
Centre declares coronavirus as 'notified disaster'
In the wake of spurt in cases of coronavirus pandemic in the country, the Ministry of Home Affairs on 14 March 2020 decided to treat Covid-19 as a "notified disaster".
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23104-centre-declares-coronavirus-as-notified-disaster.html
#coronavirus #notifieddisaster #SDRF #WHO
Community transmission of Covid-19
To rule out community transmission of Covid-19, over a thousand samples of influenza- or pneumonia-like illnesses, taken from patients without any travel history or contact with infected persons, would now also be tested for coronavirus every week.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23103-community-transmission-of-covid-19.html
#Communitytransmission #Covid19 #DHR-ICMR #coronavirus
Syrian children in need due to war: UN
The UN children’s organization UNICEF issued a plea on 13 March 2020 to support Syrian children as the war in Syria nears the start of its 10th year. A child dies every 10 hours as a result of the war, the organization said.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/23102-syrian-children-in-need-due-to-war-un.html
#UN #war #UNICEF #Syrianchildren #BasharAssad
Ksgindia
WTO-compliant remission of tax scheme | KSG India | Khan Study Group
The Cabinet Committee on Economic Affairs on 13 March 2020 approved a World Trade Organisation (WTO)-compliant scheme for reimbursement of taxes and duties to exporters. This would replace the existi
Guidelines for ARHCs
The Affordable Rental Housing Complexes (ARHCs) scheme of the Union government will allow the concessionaire to have single and double room in the complex but double room can not be more than 33% of the project.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/24774-guidelines-for-arhcs.html
#Guidelines #ARHCs #MoHUA #AKP #HardeepSinghPuri
The Affordable Rental Housing Complexes (ARHCs) scheme of the Union government will allow the concessionaire to have single and double room in the complex but double room can not be more than 33% of the project.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/24774-guidelines-for-arhcs.html
#Guidelines #ARHCs #MoHUA #AKP #HardeepSinghPuri
Ksgindia
Guidelines for ARHCs | KSG India | Khan Study Group
The Affordable Rental Housing Complexes (ARHCs) scheme of the Union government will allow the concessionaire to have single and double room in the complex but double room can not be more than 33% of t
Today's Headlines - 16 August 2023
Rule to prescribe generic drugs
GS Paper - 3 (Health and Diseases)
After the National Medical Commission notified new guidelines on professional conduct recently, doctors have been protesting one of the stipulations — using generic names of medicines on the prescription instead of a particular brand name. The Indian Medical Association, the largest body of doctors in the country, said in a statement this was akin to “running trains without tracks.”
What do the guidelines say?
The guidelines say that doctors can only write the generic names of the medicine on the prescription.
For example, a doctor will have to prescribe paracetamol for fever, instead of Dolo or Calpol Every RMP should prescribe drugs using generic names written legibly, the guidelines say.
This practice can only be relaxed for medicines with narrow therapeutic index (drugs where a small difference in dosage may lead to adverse outcomes), biosimilars (a different version of biologic products that are manufactured in living systems), and “similar other exceptional cases.”
The guideline says that generic medicines, on average, are 30% to 80% cheaper than the branded versions, and are hence likely to bring down healthcare costs.
What does it mean for you?
The new guidelines do not allow doctors to write a specific brand, which means that you will get whichever medicine with the relevant active ingredient your pharmacist stocks.
If a pharmacy does not have a generic version of a medicine — which drug stores usually do not stock because of very low profit margins — the responsibility to substitute it with a branded medicine will shift to the pharmacist instead of the doctor. This will promote brands that have good profit margins, irrespective of how good they are.
Additionally, doctors say it will also take away their choice of prescribing the medicine they think is the best for a patient.
Taken in the context of the quality of generics varying across companies, this could result in ineffective treatment.
What are the issues with generic medicines?
Doctors, drug manufacturers, and the government all agree that there is much to be done when it comes to the quality of generic medicines in the country.
While the doctors in the IMA statement said that only 0.1% medicines are tested for quality checks, manufacturers said it is not possible for the government to test every batch, but following good manufacturing practices to the T can assure quality by design.
Many have also questioned the tests that a company needs to do to get approval. Until a few years ago, it was not mandatory for companies making generics to carry out bio-equivalence or stability studies.
Bioequivalence studies are done to show that the generic drug elicits the same response as a branded version.
Stability studies are done to see how the quality of the drug varies over a period under specific environmental conditions.
Experts from the pharmaceutical sector admit that there are drugs still in the market that never underwent these studies.
Data from the Union health ministry shows that around 3% of all medicines tested over the last three years — including generics, branded generics, and branded medicines — were found to be not of standard quality.
#upsc #news #headline #rule #prescribe #generic #drugs #health #diseases #national #medical #commission #medicines #indian #doctors #tracks #trains #indian #guidelines #paracetamol #RMP #Biosimilars #index #therapeutic #cases #healthcare #pharmacist #version
Rule to prescribe generic drugs
GS Paper - 3 (Health and Diseases)
After the National Medical Commission notified new guidelines on professional conduct recently, doctors have been protesting one of the stipulations — using generic names of medicines on the prescription instead of a particular brand name. The Indian Medical Association, the largest body of doctors in the country, said in a statement this was akin to “running trains without tracks.”
What do the guidelines say?
The guidelines say that doctors can only write the generic names of the medicine on the prescription.
For example, a doctor will have to prescribe paracetamol for fever, instead of Dolo or Calpol Every RMP should prescribe drugs using generic names written legibly, the guidelines say.
This practice can only be relaxed for medicines with narrow therapeutic index (drugs where a small difference in dosage may lead to adverse outcomes), biosimilars (a different version of biologic products that are manufactured in living systems), and “similar other exceptional cases.”
The guideline says that generic medicines, on average, are 30% to 80% cheaper than the branded versions, and are hence likely to bring down healthcare costs.
What does it mean for you?
The new guidelines do not allow doctors to write a specific brand, which means that you will get whichever medicine with the relevant active ingredient your pharmacist stocks.
If a pharmacy does not have a generic version of a medicine — which drug stores usually do not stock because of very low profit margins — the responsibility to substitute it with a branded medicine will shift to the pharmacist instead of the doctor. This will promote brands that have good profit margins, irrespective of how good they are.
Additionally, doctors say it will also take away their choice of prescribing the medicine they think is the best for a patient.
Taken in the context of the quality of generics varying across companies, this could result in ineffective treatment.
What are the issues with generic medicines?
Doctors, drug manufacturers, and the government all agree that there is much to be done when it comes to the quality of generic medicines in the country.
While the doctors in the IMA statement said that only 0.1% medicines are tested for quality checks, manufacturers said it is not possible for the government to test every batch, but following good manufacturing practices to the T can assure quality by design.
Many have also questioned the tests that a company needs to do to get approval. Until a few years ago, it was not mandatory for companies making generics to carry out bio-equivalence or stability studies.
Bioequivalence studies are done to show that the generic drug elicits the same response as a branded version.
Stability studies are done to see how the quality of the drug varies over a period under specific environmental conditions.
Experts from the pharmaceutical sector admit that there are drugs still in the market that never underwent these studies.
Data from the Union health ministry shows that around 3% of all medicines tested over the last three years — including generics, branded generics, and branded medicines — were found to be not of standard quality.
#upsc #news #headline #rule #prescribe #generic #drugs #health #diseases #national #medical #commission #medicines #indian #doctors #tracks #trains #indian #guidelines #paracetamol #RMP #Biosimilars #index #therapeutic #cases #healthcare #pharmacist #version